Free Trial

ProShares Ultra Health Care Rating

ProShares Ultra Health Care logo
$47.65 -1.46 (-2.97%)
Closing price 06/17/2026 04:10 PM Eastern
Extended Trading
$47.64 -0.01 (-0.02%)
As of 06/17/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ProShares Ultra Health Care Aggregate Rating and Price Target (2026)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

RXL Aggregate Rating

Moderate Buy
2.76

Holdings in RXL have an aggregate rating of Moderate Buy based on 471 analyst ratings issued in the past year covering 19 companies (59.9% of the portfolio).

RXL Aggregate Price Target

$47.65
High Prediction$47.65
Average Prediction$47.65
Low Prediction$47.65

Holdings in RXL have an aggregate price target of $47.65 and a range of $47.65 to $47.65 covering 19 companies (59.9% of the portfolio).

RXL Consensus Ratings of Holdings

Strong Buy
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
Moderate Buy
16 Moderate Buy rating(s)
Hold
3 Hold rating(s)
Reduce
0 Reduce rating(s)
Sell
0 Sell rating(s)
Strong Sell
0 Strong Sell rating(s)

Ratings for Stocks Held by ProShares Ultra Health Care

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 19 RXL Holdings

Weight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)View
Ratings
12.32%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$1,111.43
-1.0%
4.3639 of 5 stars
2.87$1,227.74 10.5%30
7.82%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$233.44
-0.7%
4.532 of 5 stars
2.74$253.04 8.4%27
5.40%
AbbVie Inc. stock logo
ABBV
AbbVie
$221.25
-0.6%
4.5622 of 5 stars
2.88$253.43 14.5%25
5.13%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$399.33
-2.0%
4.3167 of 5 stars
2.78$409.75 2.6%27
3.93%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$115.67
+0.4%
4.5656 of 5 stars
2.68$128.18 10.8%19
2.60%
Amgen Inc. stock logo
AMGN
Amgen
$341.66
-1.8%
4.2755 of 5 stars
2.45$354.42 3.7%31
2.45%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$460.62
-2.5%
4.8899 of 5 stars
2.88$608.95 32.2%25
2.12%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$125.45
-1.4%
4.9189 of 5 stars
2.86$158.41 26.3%29
2.12%
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$88.34
-2.5%
4.9856 of 5 stars
2.85$118.30 33.9%26
2.04%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$402.18
-3.6%
4.2787 of 5 stars
2.67$573.42 42.6%27
2.04%
Pfizer Inc. stock logo
PFE
Pfizer
$25.95
-0.3%
3.9035 of 5 stars
2.25$28.82 11.1%20
1.76%
CVS Health Corporation stock logo
CVS
CVS Health
$99.06
-1.6%
4.1671 of 5 stars
2.85$100.68 1.6%26
1.58%
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$55.41
-0.9%
4.7768 of 5 stars
2.37$61.31 10.7%19
1.58%
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
$458.99
+1.3%
4.3811 of 5 stars
2.88$555.91 21.1%25
1.57%
Danaher Corporation stock logo
DHR
Danaher
$177.85
-1.9%
4.6966 of 5 stars
2.84$233.61 31.4%25
1.46%
Stryker Corporation stock logo
SYK
Stryker
$301.24
-3.0%
4.9257 of 5 stars
2.73$395.33 31.2%22
1.42%
Medtronic PLC stock logo
MDT
Medtronic
$78.04
-4.0%
4.9147 of 5 stars
2.61$99.00 26.9%28
1.32%
McKesson Corporation stock logo
MCK
McKesson
$779.00
-0.8%
4.9215 of 5 stars
2.82$960.53 23.3%17
1.22%
Elevance Health, Inc. stock logo
ELV
Elevance Health
$392.04
-1.4%
4.4732 of 5 stars
2.61$416.11 6.1%23

This page (NYSEARCA:RXL) was last updated on 6/18/2026 by MarketBeat.com Staff.
From Our Partners